The consultant, the FDA and you
Dealing with the FDA
With the FDA beginning to inspect medical companies once again following a slow down due to Covid-19, it is important – especially for new companies – to know what to do when faced with...
Expert corrective action
Manufacturers are running afoul of the US FDA’s Corrective and Preventive Action requirements, resulting in official warning letters that delay market launches. Alan Schwartz,...
